Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Curvebeam AI Ltd. ( (AU:CVB) ) has shared an announcement.
CurveBeam AI Limited has appointed Patrick Fisher as a director effective 19 March 2026, signaling a change in the company’s board composition. As part of his appointment, Fisher holds 2,500,000 share rights in the company, aligning his interests with shareholders and potentially influencing future strategic and governance decisions.
The initial director’s interest notice lodged with the ASX confirms that Fisher has no additional indirect holdings or contractual interests in CurveBeam AI securities beyond these share rights. This disclosure enhances transparency for investors and other stakeholders by clarifying the new director’s equity position at the outset of his tenure.
The most recent analyst rating on (AU:CVB) stock is a Hold with a A$0.15 price target. To see the full list of analyst forecasts on Curvebeam AI Ltd. stock, see the AU:CVB Stock Forecast page.
More about Curvebeam AI Ltd.
CurveBeam AI Limited operates in the medical imaging technology sector, focusing on advanced diagnostic imaging solutions that leverage artificial intelligence. The company targets healthcare providers and specialists seeking high-resolution, data-driven imaging capabilities to improve diagnostic accuracy and patient outcomes.
Average Trading Volume: 832,239
Technical Sentiment Signal: Sell
Current Market Cap: A$26.28M
See more insights into CVB stock on TipRanks’ Stock Analysis page.